Release Date:  March 5, 2001

NOTICE:  NOT-AI-01-019

National Institute of Allergy and Infectious Diseases

Receipt Date:  July 9, 2001

The Division of Acquired Immune Deficiency Syndrome (DAIDS) of the 
National Institute of Allergy and Infectious Diseases (NIAID), National 
Institutes of Health (NIH), has a requirement for the development of an 
efficacious vaccine against HIV for worldwide use in stemming the AIDS 
epidemic.  To augment the vaccine product pipeline, we are seeking 
opportunities to advance vaccine concepts toward the product stage via 
a focused, development-based approach.  Specifically, the long-range 
goal of this solicitation is the development of new safe and 
immunogenic vaccine candidates that merit further evaluation in larger 
human trials. The HIV Vaccine Design and Development Teams (HVDDT) 
solicitation seeks to fund consortia of scientists with development 
experience from industry and/or academia that have 1) identified a 
promising vaccine concept, and 2) envisioned its targeted development 
into a vaccine product.

A vaccine product is defined here to be a material and its manner of 
administration that could reasonably provide protection against AIDS.  
Offerors are encouraged, but not required to conduct phase I/II trials 
in collaboration with NIAID/DAIDS-supported HIV/AIDS vaccine trials 
networks.  Support for phase III studies will not be funded under this 

It is anticipated that up to six (6) cost reimbursement, completion 
type contracts will be awarded for a period of five (5) years, 
beginning approximately February 15, 2002.  RFP-NIH-NIAID-DAIDS-02-06 
will be available electronically on or about March 12, 2001, and may be 
accessed through the NIAID Contract Management Branch (CMB) Home Page 
using the following address http://www.niaid.nih.gov/contract/. Select 
the link “RFPs” and then select “RFP-NIH-NIAID-DAIDS-02-06.”  Please 
note that the RFP for this acquisition has been revised to include only 
the Work Statement, deliverable and reporting requirements, special 
requirements and mandatory qualification, if any, the Technical 
Evaluation Criteria, and the proposal preparation instructions.  All 
information required for the submission of an offer will be contained 
in the electronic RFP package.  Following proposal submission and the 
initial review process, Offerors comprising the competitive range will 
be requested to provide additional documentation to the Contracting 

Responses to this RFP will be due on July 9, 2001.  Any responsible 
Offeror may submit a proposal that will be considered by the 

This advertisement does not commit the Government to award a contract.

Point of Contact:  Joshua LaVine, Contract Specialist
Email:  Jl276z@nih.gov
Tel:  301-496-2509 (via tty 1-800-735-2258)
FAX:  301-402-0972

No collect calls will be accepted.

Return to Volume Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.